Retention in an antiretroviral therapy programme during an era of decreasing drug cost in Limbe, Cameroon.
about
Population-based monitoring of emerging HIV-1 drug resistance on antiretroviral therapy and associated factors in a sentinel site in Cameroon: low levels of resistance but poor programmatic performanceRetention and risk factors for attrition in a large public health ART program in Myanmar: a retrospective cohort analysis.Time-Dependent Predictors of Loss to Follow-Up in a Large HIV Treatment Cohort in Nigeria.Male, mobile, and moneyed: loss to follow-up vs. transfer of care in an urban African antiretroviral treatment clinic.Trends in mortality and loss to follow-up in HIV care at the Nkongsamba Regional hospital, Cameroon.Retention of Adult Patients on Antiretroviral Therapy in Low- and Middle-Income Countries: Systematic Review and Meta-analysis 2008-2013Trends and determining factors associated with adherence to antiretroviral therapy (ART) in Cameroon: a systematic review and analysis of the CAMPS trial.The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa.The vulnerability of men to virologic failure during antiretroviral therapy in a public routine clinic in Burkina Faso.A workshop report on HIV mHealth synergy and strategy meeting to review emerging evidence-based mHealth interventions and develop a framework for scale-up of these interventions.Gender differences in enrolment in an HIV-treatment programme in rural Lesotho, 2006-2008: a brief report.Improvement in mortality and retention among adult HIV-infected patients in the first 12 months of antiretroviral therapy in Dodoma urban district, Tanzania.Improving retention in HIV care among adolescents and adults in low- and middle-income countries: A systematic review of the literature.
P2860
Q28535652-E86F46E6-FE30-455A-A3DE-6D2BB0ED8F85Q34277977-A6E40749-FB3D-44B1-9DD9-7DD0F5619627Q34802301-93555974-5F46-4726-B929-EF9F3B1D7853Q35036828-D552EE05-20EF-40D4-BBCB-C839FC80B47EQ35059630-41029AC7-2E09-45C4-B96C-ED2603E0F528Q35576031-45F95485-F8F6-48B3-B9BD-30679D26EDAFQ36510542-C62B4501-540F-42D7-A6C0-8ACC65F69874Q37455928-0E5C0AA1-B438-4640-8EB3-3A445BE5DB45Q37491656-9DDE9EA2-A279-451C-91B9-F7A5044B7D93Q37970346-304D4930-B92B-4F58-A35B-9945C6B17618Q38429613-4BCCBBAB-EB49-423E-B71E-38ED2DA2A17CQ40258969-AB8AE2C9-9E63-4C58-A81A-007DD60FEECDQ42367517-AAC62CBA-39B4-49AB-A115-FC80E3D43030
P2860
Retention in an antiretroviral therapy programme during an era of decreasing drug cost in Limbe, Cameroon.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Retention in an antiretroviral ...... drug cost in Limbe, Cameroon.
@ast
Retention in an antiretroviral ...... drug cost in Limbe, Cameroon.
@en
type
label
Retention in an antiretroviral ...... drug cost in Limbe, Cameroon.
@ast
Retention in an antiretroviral ...... drug cost in Limbe, Cameroon.
@en
prefLabel
Retention in an antiretroviral ...... drug cost in Limbe, Cameroon.
@ast
Retention in an antiretroviral ...... drug cost in Limbe, Cameroon.
@en
P2093
P2860
P356
P1476
Retention in an antiretroviral ...... drug cost in Limbe, Cameroon.
@en
P2093
Asabi J Aweh
Jembia J Mosoko
John T Brooks
Paul J Weidle
Pratima L Raghunathan
Sherri Pals
Thompson N Kinge
Wilfred Akam
P2860
P2888
P356
10.1186/1758-2652-14-32
P577
2011-06-16T00:00:00Z
P5875
P6179
1026476195